Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-2-9
|
pubmed:abstractText |
A series of aminoethylpyrrolidine-platinum complexes were synthesized and partially characterized for chemical structure. The leaving groups in this series of complexes were varied in an attempt to identify cytotoxic, water-soluble aminoethylpyrrolidine-platinum complexes. The cytotoxic activity was tested in vitro against L1210 cells sensitive to cis-diamminedichloroplatinum(II) (L1210/0), L1210 cells resistant to cis-diamminedichloroplatinum(II) (L1210/DDP), and L1210 cells resistant to 1,2-diaminocyclohexane platinum (L1210/DACH). The complexes were also tested for in vivo antitumor activity against L1210/0 cells injected i.p. The results of these studies indicate that the aminoethylpyrrolidine-platinum complexes have moderate antitumor activity but are cross-resistant in L1210/DDP cells. The degree of antitumor activity was dependent on the characteristic leaving group of a given complex.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2909285-Animals,
pubmed-meshheading:2909285-Antineoplastic Agents,
pubmed-meshheading:2909285-Drug Resistance,
pubmed-meshheading:2909285-Humans,
pubmed-meshheading:2909285-Leukemia L1210,
pubmed-meshheading:2909285-Male,
pubmed-meshheading:2909285-Mice,
pubmed-meshheading:2909285-Organoplatinum Compounds,
pubmed-meshheading:2909285-Pyrroles,
pubmed-meshheading:2909285-Solubility,
pubmed-meshheading:2909285-Structure-Activity Relationship
|
pubmed:year |
1989
|
pubmed:articleTitle |
Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes.
|
pubmed:affiliation |
Vermont Regional Cancer Center, University of Vermont, Burlington 05405.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|